Amanote Research
Register
Sign In
Analysis of Antitumor Activity of an Interleukin-13 (IL-13) Receptor-Targeted Cytotoxin Composed of IL-13 Antagonist and Pseudomonas Exotoxin
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-04-0700
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
September 15, 2004
Authors
M. Kioi
Publisher
American Association for Cancer Research (AACR)
Related search
Specific Targeting of Human Interleukin (IL)-13 Receptor Α2-Positive Cells With Lentiviral Vectors Displaying IL-13
Human gene therapy methods
Applied Microbiology
Biotechnology
Genetics
Pharmacology
Molecular Medicine
Interleukin-5 (IL-5) Augments the Progression of Liver Fibrosis by Regulating IL-13 Activity
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Induction of the IL-13 Receptor Α2-Chain by IL-4 and IL-13 in Human Keratinocytes: Involvement of STAT6, ERK and P38 MAPK Pathways
Oncogene
Cancer Research
Genetics
Molecular Biology
Interleukin 13-Mediated Colitis in the Absence of IL-4Rα Signalling
Gut
Gastroenterology
Interleukin (IL) 4 and IL-13 Act on Human Lung Fibroblasts. Implication in Asthma.
Journal of Clinical Investigation
Medicine
Real-Time, Image-Guided, Convection-Enhanced Delivery of Interleukin 13 Bound to Pseudomonas Exotoxin
Clinical Cancer Research
Cancer Research
Oncology
Identification, Purification, and Characterization of a Soluble Interleukin (IL)-13-binding Protein
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Adenosine Mediates IL-13–induced Inflammation and Remodeling in the Lung and Interacts in an IL-13–adenosine Amplification Pathway
Journal of Clinical Investigation
Medicine
RPC4046, a Novel Anti-Interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 Α1 and Α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-In-Human Study
Advances in Therapy
Medicine
Pharmacology
